IntroductionCytokines play critical roles during hematopoietic development. 1 Some, such as stem cell factor (SCF), regulate early hematopoiesis through their action on multipotent progenitors. 1 Others, such as erythropoietin (Epo), regulate later stages of hematopoiesis through their effects on specific, lineage-committed cells. 1 Thrombopoietin (Tpo), while first identified as a key cytokine regulator of megakaryocyte-lineage development, 2-5 also plays a vital role in hematopoietic progenitor or stem cell biology. 6,7 Cytokine effects are mediated by the activation of specific intracellular signaling pathways following binding to their cognate receptors.While the intracellular signaling pathways activated by most hematopoietic cytokines have been identified, their biologic significance remains poorly understood. The classic mitogen-activated protein (MAP) kinase (Raf/MEK/extracellular signal-related kinase [ERK]) intracellular pathway can affect cell proliferation, apoptosis, and differentiation in various cell lines and systems, 8,9 yet its role in hematopoiesis remains undefined. Moreover, since the MAP kinase cascade is activated by various cytokines, one would predict that its function is context dependent.As an entry point to the classic MAP kinase pathway, Raf kinases play a key role in controlling the signal flow from activated cytokine receptors by activating MAP kinase/ERK kinase 1/2 (MEK 1/2), which in turn activates ERK 1/2, the pathway's key known effector. 10 There are 3 known vertebrate Raf isoforms, A-Raf, B-Raf, and Raf-1. 11 We recently reported that Raf-1 is not required for establishment of the myeloid progenitor compartment in murine bone marrow, megakaryocytopoiesis, or Tpo-induced ERK phosphorylation. 12 As the Raf/MEK/ERK pathway is activated by a number of cytokines, including Tpo, and our Raf-1 findings raised questions about previously reported roles for Raf-1 in megakaryocytopoiesis, 13 we have extended our genetic approach to better understand the role of other Raf family members in myeloid development, including megakaryocytopoiesis.While Raf-1 is the most studied Raf family member, B-Raf is more widely expressed than originally thought and is possibly the most potent MEK/ERK activator among the Raf isoforms. 11,14 Recent reports suggest an important role for B-Raf in a number of pathologic and physiologic events including melanoma, thyroid, ovarian, and colon cancer 15 ; sensory and motor neuron survival 16 ; and midgestational mouse embryogenesis. [17][18][19] Moreover, the classic MAP kinase cascade is frequently activated in leukemia. This is most often due to Ras activating mutations, 20 but primary B-raf mutations have been identified in acute leukemias and malignant lymphomas. [21][22][23] Despite the important role of Ras activating mutations in hematopoietic pathology, and the recent entry of Raf inhibitors into clinical trails, 24-26 the role of B-Raf in hematopoiesis remains undefined.In this study, we characterized the role of B-Raf in myelopoiesis using B-raf Ϫ/Ϫ emb...